Dr. Khaled Alhawiti | Parkinson’s Monitoring | Best Researcher Award

Dr. Khaled Alhawiti | Parkinson’s Monitoring | Best Researcher Award 

Dr. Khaled Alhawiti | Parkinson’s Monitoring | University of Tabuk | Saudi Arabia

Dr. Khaled M. Alhawiti is an accomplished Associate Professor in the Faculty of Computers and Information Technology at the University of Tabuk, recognized for his scholarly contributions in artificial intelligence, natural language processing, and Arabic language processing. He completed his Ph.D. in Computer Science from the University of Wales, Bangor University, where he focused on computational models and language technologies that support intelligent information processing. His academic path includes a Master of Science in Information Technology from the University of Technology Malaysia and a Bachelor’s degree in Computer Science from the University of Jordan, reflecting strong foundations in computing and higher education across multiple countries. Professionally, Dr. Khaled M. Alhawiti has built extensive experience in teaching, mentoring, research development, and academic leadership, actively contributing to curriculum enhancement and collaborative research initiatives within his institution and beyond. His research interests span artificial intelligence, data science, natural language processing, Arabic text modeling, speech-based systems, and intelligent educational technologies. He possesses strong research skills in machine learning, adaptive modeling, text compression techniques, rule-based systems, language preprocessing, and large-scale corpus analysis. His publications have been widely cited and indexed in Scopus and leading AI venues, demonstrating the impact of his contributions to computational linguistics and AI-driven text analysis. Dr. Khaled M. Alhawiti has collaborated on multiple international research activities, contributing to academic exchanges across Saudi Arabia, Malaysia, the United Kingdom, and Jordan, strengthening global partnerships in computer science. His awards and honors include recognition for high-impact publications, contributions to AI education research, and active participation in academic committees and professional societies. He is also associated with leading research communities such as IEEE and ACM, promoting engagement in emerging technological advancements.

Professional Profiles: ORCID  | Google Scholar

Featured Publications 

  1. Alhawiti, K. M. (2014). Natural language processing and its use in education. 161 citations.

  2. Alhawiti, K. M. (2015). Advances in artificial intelligence using speech recognition. 42 citations.

  3. Alhawiti, K. M. (2014). Adaptive models of Arabic text. 20 citations.

  4. Zerrouki, T., Alhawiti, K., & Balla, A. (2014). Autocorrection of Arabic common errors for large text corpus. 16 citations.

  5. Teahan, W. J., & Alhawiti, K. M. (2015). Preprocessing for PPM: Compressing UTF-8 encoded natural language text. 13 citations.

  6. Elfaki, A. O., Alhawiti, K. M., AlMurtadha, Y. M., Abdalla, O. A., & Elshiekh, A. A. (2014). Rule-based recommendation for supporting student learning-pathway selection. 13 citations.

  7. Alhawiti, K. M. (2014). Adaptive Arabic text modeling using computational techniques. (Derived from thesis-related work). 20 citations.

Dr. Rabab Al-Lahham | Neurology Awards | Best Researcher Award

Dr. Rabab Al-Lahham | Neurology Awards | Best Researcher Award

Dr. Rabab Al-Lahham, Utmb, United States

Dr. Rabab Al-Lahham is an Assistant Professor in the Department of Pharmacology and Toxicology at the John Sealy School of Medicine, University of Texas Medical Branch (UTMB) at Galveston. She earned her Ph.D. in Pharmacology and Toxicology from UTMB, where her doctoral work focused on mitochondrial-generated ROS and its role in insulin signaling via the p38 MAPK stress response pathway. Dr. Al-Lahham also holds an M.A. in Clinical Chemistry from the University of Scranton and a B.S. in Pharmacy from the University of Jordan. Her postdoctoral training includes research at UTMB and the University of Texas Health Science Center at Houston, where she contributed to studies on neurodegenerative diseases, including Alzheimer’s and Parkinson’s. Her current research investigates the role of liver-derived FGF21 and AhR activity in neurodegenerative pathogenesis and the effects of cocaine on brain disease progression. Dr. Al-Lahham has co-authored numerous publications in high-impact journals and has experience in both academic teaching and pharmaceutical research across multiple institutions.

Professional Profile:

ORCID

GOOGLE SCHOLAR

Summary of Suitability for the Best Researcher Award: Dr. Rabab Al-Lahham

Dr. Rabab Al-Lahham holds a PhD in Pharmacology and Toxicology from the University of Texas Medical Branch (UTMB), with a strong foundation in molecular mechanisms of disease, including mitochondrial function and signaling pathways related to insulin resistance and oxidative stress. Her earlier degrees in Clinical Chemistry and Pharmacy provide a solid multidisciplinary scientific background.

🎓 Education

  • PhD in Pharmacology and Toxicology
    University of Texas Medical Branch (2004–2011)
    Dissertation: Mitochondrial-Generated ROS Downregulates Insulin Signaling via Activation of the p38 MAPK Stress Response Pathway

  • MA in Clinical Chemistry
    University of Scranton (1999–2002)
    Thesis: Development of a Novel and Sensitive RT-PCR Assay for Detection of ErbB2 Expression in Breast Cancer

  • BS in Pharmacy
    University of Jordan (1987–1992)
    Graduated second rank with University Honors

💼 Work Experience

  • Assistant Professor
    Dept. of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX (2025–present)

  • Instructor
    Dept. of Pharmacology and Toxicology, University of Texas Medical Branch (2023–2025)

  • Postdoctoral Research Fellow
    Various labs at University of Texas Medical Branch and University of Texas Health Science Center (2012–2023)

  • Graduate Assistant & Teaching Assistant
    University of Texas Medical Branch & University of Scranton (2000–2011)

  • Clinical Pharmacist & Research Assistant
    Various roles in Jordan, Saudi Arabia, and Aventis Pasteur (1993–2000)

🏆 Achievements & Research Highlights

  • Principal Investigator on multiple funded projects related to Alzheimer’s disease and neurodegenerative diseases

  • Identified fluorescent probes for Alzheimer’s Aβ deposits detection

  • Contributed to research on Parkinson’s disease pathology using midbrain organoids

  • Investigated tau protein’s role in insulin resistance and Alzheimer’s pathology

  • Developed insights into liver-derived FGF21 in neuroprotection and obesity mechanisms

  • Extensive collaboration on neural stem cell therapy and prion diseases

  • Active editorial board member and journal reviewer in neuroscience and molecular biosciences

🎖️ Awards & Honors

  • Neuroscience Poster Session Award (2021) 🧠

  • American Neurological Association Travel Award (2018) ✈️

  • Alzheimer’s Association International Conference Travel Award (2018) 🧬

  • Sealy Center for Vaccine Development Travel Award (2018) 💉

  • Best Poster Award in Pharmacology and Toxicology (2011) 🏅

  • Edward S. Reynolds Investigative Pathology Memorial Award (2011) 🔬

  • Multiple Annual Forum on Aging Poster Awards (2006, 2008, 2009) 👵👴

  • George Palmer Saunders II Memorial Scholarship (2009) 🎓

  • ‘Who’s Who Among Students in American Universities and Colleges’ (2001) 🌟

  • Frank O’Hara Award of Excellence (2001) 🏆

Publication Top Notes:

Intracellular Inclusions Induced by Patient-Derived and Amplified α-Synuclein Aggregates Are Morphologically Indistinguishable

Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance

Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease Patient.

Identification of Multicolor Fluorescent Probes for Heterogeneous Aβ Deposits in Alzheimer’s Disease

Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner.

Tau deletion or loss of function promotes peripheral insulin resistance

Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin

O5‐05‐06: EVALUATING TAU OLIGOMERS PASSIVE IMMUNOTHERAPY USING AGED TRANSGENIC ANIMALS OF TAUOPATHY

Mitochondrial-generated ROS down regulates insulin signaling via activation of the p38MAPK stress response pathway